IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally.
Aileron Therapeutics, Inc. (ALRN)
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States.